Vlad Coric

2018 - Biohaven Pharmaceutical Holding Co Ltd.

In 2018, Vlad Coric earned a total compensation of $7.9M as Chief Executive Officer at Biohaven Pharmaceutical Holding Co Ltd., a 104% increase compared to previous year.

Compensation breakdown

Bonus$437,500
Option Awards$6,904,000
Salary$500,000
Other$12,500
Total$7,854,000

Coric received $6.9M in option awards, accounting for 88% of the total pay in 2018.

Coric also received $437.5K in bonus, $500K in salary and $12.5K in other compensation.

Rankings

In 2018, Vlad Coric's compensation ranked 1,046th out of 14,244 executives tracked by ExecPay. In other words, Coric earned more than 92.7% of executives.

ClassificationRankingPercentile
All
1,046
out of 14,244
93rd
Division
Manufacturing
348
out of 5,765
94th
Major group
Chemicals And Allied Products
109
out of 2,128
95th
Industry group
Drugs
85
out of 1,817
95th
Industry
Pharmaceutical Preparations
59
out of 1,391
96th
Source: SEC filing on April 11, 2019.

Coric's colleagues

We found four more compensation records of executives who worked with Vlad Coric at Biohaven Pharmaceutical Holding Co Ltd. in 2018.

2018

James Engelhart

Biohaven Pharmaceutical Holding Co Ltd.

Chief Financial Officer

2018

Charles Conway

Biohaven Pharmaceutical Holding Co Ltd.

Chief Scientific Officer

2018

Kimberly Gentile

Biohaven Pharmaceutical Holding Co Ltd.

SVP, Clinical Operations

2018

John Tilton

Biohaven Pharmaceutical Holding Co Ltd.

Chief Commercial Officer

News

In-depth

You may also like